LIGAND PHARMACEUTICALS INC (LGND) 8-K Current Report — February 26, 2026
Filed: February 26, 2026
Health Care
Pharmaceutical PreparationsLIGAND PHARMACEUTICALS INC (LGND) 8-K current report filed with SEC EDGAR on February 26, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
LIGAND PHARMACEUTICALS INC 8-K Feb 26, 2026 Event Analysis
Item 2.02 · Results of Operations and Financial Condition
- • Q4 and full-year 2025 earnings announced Feb 26, 2026; results in Exhibit 99.1
- • Filing covers periods ending Dec 31, 2025 — key figures in the press release, not in this item
Get deeper insights on LIGAND PHARMACEUTICALS INC
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.